ATBF1-A messenger RNA expression is correlated with better prognosis in breast cancer

Clinical Cancer Research

Volumn 11, Issue 1, 2005, Pages 193-198

  Zhang, Zhenhuan ^a   Yamashita, Hiroko ^a   Toyama, Tatsuya ^a   Sugiura, Hiroshi ^a   Ando, Yoshiaki ^a   Mita, Keiko ^a   Hamaguchi, Maho ^a   Kawaguchi, Makoto ^b   Miura, Yutaka ^a   Iwase, Hirotaka ^a,c  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^b Japan Organization of Occupational Health and Safety   (Japan)

^c NAGOYA CITY UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AT MOTIF BINDING FACTOR 1 A; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER GROWTH; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HORMONE RELEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; AMINO ACID MOTIFS; BREAST NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; STOMACH NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 19944426049     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Nakabayashi H, Watanabe K, Saito A, Otsuru A, Sawadaishi K, Tamaoki T. Transcriptional regulation of α-fetoprotein expression by dexamethasone in human hepatoma cells. J Biol Chem 1989;264:266-71.
2. Watanabe K, Saito A, Tamaoki T. Cell-specific enhancer activity in a far upstream region of the human α-fetoprotein gene. J Biol Chem 1987;262:4812-8.
3. Sawadaishi K, Morinaga T, Tamaoki T. Interaction of a hepatoma-specific nuclear factor with transcription-regulatory sequences of the human α-fetoprotein and albumin genes. Mol Cell Biol 1988;8:5179-87.
4. Morinaga T, Yasuda H, Hashimoto T, Higashio K, Tamaoki T. A human α-fetoprotein enhancer-binding protein, ATBF1, contains four homeodomains and seventeen zinc fingers. Mol Cell Biol 1991;11:6041-9.
5. Miura Y, Tam T, Ido A, et al. Cloning and characterization of an ATBF1 isoform that expresses in a neuronal differentiation-dependent manner. J Biol Chem 1995;270:26840-8.
6. Berry FB, Miura Y, Mihara K, et al. Positive and negative regulation of myogenic differentiation of C2C12 cells by isoforms of the multiple homeodomain zinc finger transcription factor ATBF1. J Biol Chem 2001;276:25057-65.
7. Kataoka H, Miura Y, Joh T, et al. α-Fetoprotein producing gastric cancer lacks transcription factor ATBF1. Oncogene 2001;20:869-73.
8. Kaspar P, Dvorakova M, Kralova J, Pajer P, Kozmik Z, Dvorak M. Myb-interacting protein, ATBF1, represses transcriptional activity of Myb oncoprotein. J Biol Chem 1999;274:14422-8.
9. Miura Y, Kataoka H, Joh T, et al. Susceptibility to killer T cells of gastric cancer cells enhanced by Mitomycin-C involves induction of ATBF1 and activation of p21 (Waf1/Cip1) promoter. Microbiol Immunol 2004;48:137-45.
10. Kawaguchi M, Miura Y, Ido A, et al. DNA/RNA-dependent ATPase activity is associated with ATBF1, a multiple homeodomain-zinc finger protein. Biochim Biophys Acta 2001;1550:164-74.
11. Yamada K, Miura Y, Scheidl T, Yoshida MC, Tamaoki T. Assignment of the human ATBF1 transcription factor gene to chromosome 16q22.3-q23.1. Genomics 1995;29:552-3.
12. Devilee P, van Vliet M, van Sloun P, et al. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 1991;6:1705-11.
13. Ando Y, Iwase H, Ichihara S, et al. Loss of heterozygosity and microsatellite instability in ductal carcinoma in situ of the breast. Cancer Lett 2000;156:207-14.
14. Goldhirsch A, Wood WC, Senn HJ, Glick JH, Gelber RD. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1995;87:1441-5.
15. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
16. Harada N, Hatano O. Inhibitors of aromatase prevent degradation of the enzyme in cultured human tumour cells. Br J Cancer 1998;77:567-72.
17. Toyama T, Iwase H, Watson P, et al. Suppression of ING1 expression in sporadic breast cancer. Oncogene 1999;18:5187-93.
18. Zhang Z, Yamashita H, Toyama T, et al. Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast. Breast Cancer Res 2003;5:R250-6.
19. Bieche I, Laurendeau I, Tozlu S, et al. Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay. Cancer Res 1999;59:2759-65.
20. Ishii Y, Kawaguchi M, Takagawa K, et al. ATBF1-A protein, but not ATBF1-B, is preferentially expressed in developing rat brain. J Comp Neurol 2003;465:57-71.
21. Zhang Z, Yamashita H, Toyama T, et al. Semi-quantitative immunohistochemical analysis of aromatase expression in ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2002;74:47-53.
22. Iwase H, Zhang Z, Omoto Y, et al. Clinical significance of the expression of estrogen receptors α and β for endocrine therapy of breast cancer. Cancer Chemother Pharmacol 2003;52 Suppl 1:S34-8.
23. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-81.
24. Kataoka H, Joh T, Miura Y, et al. AT motif binding factor 1-A (ATBF1-A) negatively regulates transcription of the aminopeptidase N gene in the crypt-villus axis of small intestine. Biochem Biophys Res Commun 2000;267:91-5.